Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New insights into foot and mouth disease virus
Scientists previously thought that FMDV evolution is mainly driven by mutations caused by small copying errors.
Study shows recombination is a major driver of FMDV evolution 

A study by the Pirbright Institute has revealed new insights into the evolution of foot and mouth disease virus (FMDV).

The research, published in PLOS Pathogens, found that different FMDV populations swap sections of genetic material at a far higher rate than previously thought. The information will help scientists understand how the frequency of these changes can shape virus evolution and cause new outbreaks.

Until now, scientists believed that FMDV evolution is mainly driven by mutations - caused by small copying errors that accumulate in the RNA genome of the virus when it replicates, known as substitutions. In this new study, however, researchers show that mutations caused by viral recombination events, where different FMD viruses infecting the same animal swap sections of their genome, occur almost as often as substitutions.

To show that these recombination events occur, the team injected African buffaloes with two similar FMDV strains, and then examined changes in regions of the genomes that code for proteins in the FMDV outer shell, called the capsid. The host immune system targets capsid proteins to control infection, but changes in those proteins can sometimes prevent the immune system from recognising the virus, allowing it to ‘escape’ and potentially cause a new outbreak.

Their study also revealed that levels of recombination were up to 40 times higher in the initial phase of infection compared to later on during the persistent phase, indicating that new variants of FMDV are most likely to be created soon after an animal becomes infected.

The results align with previous research by Pirbrgith that demonstrates persistently-infected African buffaloes are unlikely to generate new FMDV variations and cause new outbreaks. Researchers say this is important because African buffalo act as a reservoir for FMD, carrying the virus for years without presenting clinical signs.

“The number of recombination events we saw between the two viruses used in this research was surprising”, said Professor Bryan Charleston, Director of The Pirbright Institute. “This tells us that recombination is a major driver of FMDV evolution and understanding the mechanisms that determine how new strains are generated could help researchers analyse emerging FMD outbreaks in the field.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.